Skip to main content

Thermo Fisher Scientific ratios

  • TMO · NYSE
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$700.22+0.11%Close 13 Nov 2026

In fiscal 2025 (the year to 31 Dec 2025), Thermo Fisher Scientific had an operating margin of 17.4%, a return on equity of 13.0%, a return on invested capital of 8.2%.

From Thermo Fisher Scientific's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

Thermo Fisher Scientific ratios, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Gross margin47.9%49.5%48.0%49.3%50.4%51.2%51.8%53.0%55.3%55.1%57.1%44.6%44.4%49.7%50.1%42.2%39.9%41.3%40.9%
Operating margin10.0%11.7%10.1%11.4%10.8%11.8%12.3%14.8%13.8%13.5%14.2%15.5%18.0%24.2%25.6%18.7%16.0%17.1%17.4%
Net margin7.7%9.3%8.6%10.0%11.5%9.4%9.7%11.2%11.6%11.1%10.6%12.1%14.5%19.8%19.7%15.5%14.0%14.8%15.0%
Free cash flow margin13.4%11.0%14.7%12.1%12.4%13.8%13.2%13.0%14.8%15.4%16.7%15.5%15.8%21.2%17.3%15.4%16.2%16.9%14.1%
Return on equity5.2%6.7%5.6%6.7%8.7%7.7%7.9%10.1%9.4%9.4%9.5%11.1%12.9%19.9%20.5%16.4%13.2%13.2%13.0%
Return on assets—5.0%4.4%5.0%4.7%5.4%5.3%6.1%4.4%4.5%5.3%6.0%7.3%10.8%10.7%7.9%6.7%6.8%6.9%
Return on capital employed—6.3%5.1%6.0%5.8%6.0%6.0%7.6%6.3%6.3%6.5%7.6%9.0%14.1%14.3%10.4%8.3%8.7%8.6%
Return on invested capital—5.8%5.1%5.7%5.2%6.0%6.4%7.2%4.8%4.9%5.9%6.8%8.2%13.2%13.0%9.4%8.0%8.0%8.2%
Current ratio—2.822.762.421.552.313.161.221.381.441.341.731.922.131.501.481.751.661.89
Debt to equity—0.140.140.140.470.460.620.710.580.770.830.690.620.650.890.820.780.660.76
Net debt / EBITDA—0.360.350.632.852.561.783.152.993.763.942.792.341.212.522.342.762.602.92
Interest coverage—8.118.4914.037.146.136.145.225.635.245.005.676.8014.0918.7111.564.995.285.46
Cash conversion175%118%172%121%108%146%136%116%128%139%157%129%109%107%87.9%99.4%116%115%93.9%
Dividend payout————0.0%12.1%17.0%12.4%12.2%11.8%10.7%9.1%8.0%5.3%5.1%6.5%8.7%9.2%9.5%
SBC / Revenue0.5%0.5%0.7%0.8%0.7%0.6%0.7%0.7%0.7%0.7%0.8%0.7%0.7%0.6%0.6%0.7%0.6%0.7%0.7%

Quarterly

Thermo Fisher Scientific ratios, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Gross margin40.4%40.6%41.2%40.8%42.3%40.9%40.6%41.2%41.0%40.3%40.7%42.3%
Operating margin17.0%16.1%17.3%17.3%17.7%16.6%16.9%17.5%18.5%16.9%17.4%18.6%
Net margin15.0%12.8%14.7%15.4%16.1%14.5%14.9%14.5%16.1%15.0%14.5%14.2%
Free cash flow margin30.5%8.7%15.7%17.9%24.7%3.5%10.2%16.5%24.5%7.4%14.0%17.4%
Return on equity3.5%2.9%3.3%3.3%3.7%3.1%3.2%3.2%3.7%3.2%3.3%3.1%
Return on assets1.7%1.4%1.7%1.7%1.9%1.6%1.7%1.7%1.9%1.6%1.7%1.6%
Return on capital employed2.2%2.0%2.2%2.1%2.4%2.0%2.1%2.2%2.4%1.9%2.1%2.3%
Return on invested capital2.1%1.6%2.0%2.0%2.2%1.9%2.0%1.9%2.3%1.8%1.9%1.9%
Current ratio1.751.701.721.631.661.771.931.501.891.531.551.81
Debt to equity0.780.780.750.720.660.690.700.700.760.830.810.76
Net debt / EBITDA10.5311.3510.1811.129.8611.6711.4412.3510.3115.3513.2511.43
Interest coverage4.754.585.145.166.365.664.545.596.185.265.205.43
Cash conversion204%68.1%107%116%154%24.0%68.3%114%152%49.4%96.5%123%
Dividend payout8.3%10.2%9.6%9.2%8.1%9.9%10.0%10.1%8.2%9.8%10.1%10.1%
SBC / Revenue0.6%0.7%0.8%0.6%0.7%0.7%0.7%0.6%0.7%0.8%0.7%0.8%

The main figures as JSON and plain text. See data and methodology.

TMO in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.